Literature DB >> 29848777

Novel Paradigms Governing β1-Adrenergic Receptor Trafficking in Primary Adult Rat Cardiac Myocytes.

Mohammed M Nooh1, Salvatore Mancarella1, Suleiman W Bahouth2.   

Abstract

The β1-adrenergic receptor (β1-AR) is a major cardiac G protein-coupled receptor, which mediates cardiac actions of catecholamines and is involved in genesis and treatment of numerous cardiovascular disorders. In mammalian cells, catecholamines induce the internalization of the β1-AR into endosomes and their removal promotes the recycling of the endosomal β1-AR back to the plasma membrane; however, whether these redistributive processes occur in terminally differentiated cells is unknown. Compartmentalization of the β1-AR in response to β-agonists and antagonists was determined by confocal microscopy in primary adult rat ventricular myocytes (ARVMs), which are terminally differentiated myocytes with unique structures such as transverse tubules (T-tubules) and contractile sarcomeres. In unstimulated ARVMs, the fluorescently labeled β1-AR was expressed on the external membrane (the sarcolemma) of cardiomyocytes. Exposing ARVMs to isoproterenol redistributed surface β1-ARs into small (∼225-250 nm) regularly spaced internal punctate structures that overlapped with puncta stained by Di-8 ANEPPS, a membrane-impermeant T-tubule-specific dye. Replacing the β-agonist with the β-blocker alprenolol, induced the translocation of the wild-type β1-AR from these punctate structures back to the plasma membrane. This step was dependent on two barcodes, namely, the type-1 PDZ binding motif and serine at position 312 of the β1-AR, which is phosphorylated by a pool of cAMP-dependent protein kinases anchored at the type-1 PDZ of the β1-AR. These data show that redistribution of the β1-AR in ARVMs from internal structures back to the plasma membrane was mediated by a novel sorting mechanism, which might explain unique aspects of cardiac β1-AR signaling under normal or pathologic conditions.
Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29848777      PMCID: PMC6022806          DOI: 10.1124/mol.118.112045

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  58 in total

Review 1.  Catecholamines, cardiac beta-adrenergic receptors, and heart failure.

Authors:  R J Lefkowitz; H A Rockman; W J Koch
Journal:  Circulation       Date:  2000-04-11       Impact factor: 29.690

2.  Internalization of ionotropic glutamate receptors in response to mGluR activation.

Authors:  E M Snyder; B D Philpot; K M Huber; X Dong; J R Fallon; M F Bear
Journal:  Nat Neurosci       Date:  2001-11       Impact factor: 24.884

3.  Regulation of cardiac inward rectifier potassium current (I(K1)) by synapse-associated protein-97.

Authors:  Ravi Vaidyanathan; Steven M Taffet; Karen L Vikstrom; Justus M B Anumonwo
Journal:  J Biol Chem       Date:  2010-06-08       Impact factor: 5.157

Review 4.  Methods in cardiomyocyte isolation, culture, and gene transfer.

Authors:  William E Louch; Katherine A Sheehan; Beata M Wolska
Journal:  J Mol Cell Cardiol       Date:  2011-06-24       Impact factor: 5.000

5.  Changes in T-Tubules and Sarcoplasmic Reticulum in Ventricular Myocytes in Early Cardiac Hypertrophy in a Pressure Overload Rat Model.

Authors:  Perla Pérez-Treviño; Jorge Pérez-Treviño; Cuauhtémoc Borja-Villa; Noemí García; Julio Altamirano
Journal:  Cell Physiol Biochem       Date:  2015-10-22

Review 6.  Compartmentation of cyclic nucleotide signaling in the heart: the role of cyclic nucleotide phosphodiesterases.

Authors:  Rodolphe Fischmeister; Liliana R V Castro; Aniella Abi-Gerges; Francesca Rochais; Jonas Jurevicius; Jérôme Leroy; Grégoire Vandecasteele
Journal:  Circ Res       Date:  2006-10-13       Impact factor: 17.367

7.  Selective enhancement by serum factors of cyclic AMP accumulation in rat microglial cultures.

Authors:  M Patrizio; D Riitano; T Costa; G Levi
Journal:  Neurochem Int       Date:  1996-07       Impact factor: 3.921

8.  Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts.

Authors:  M R Bristow; R Ginsburg; W Minobe; R S Cubicciotti; W S Sageman; K Lurie; M E Billingham; D C Harrison; E B Stinson
Journal:  N Engl J Med       Date:  1982-07-22       Impact factor: 91.245

Review 9.  Retromer-mediated endosomal protein sorting: all WASHed up!

Authors:  Matthew N J Seaman; Alexis Gautreau; Daniel D Billadeau
Journal:  Trends Cell Biol       Date:  2013-05-28       Impact factor: 20.808

10.  Spatially restricted G protein-coupled receptor activity via divergent endocytic compartments.

Authors:  Frederic Jean-Alphonse; Shanna Bowersox; Stanford Chen; Gemma Beard; Manojkumar A Puthenveedu; Aylin C Hanyaloglu
Journal:  J Biol Chem       Date:  2013-12-27       Impact factor: 5.157

View more
  3 in total

1.  Subcellular β-Adrenergic Receptor Signaling in Cardiac Physiology and Disease.

Authors:  Wenhui Wei; Alan V Smrcka
Journal:  J Cardiovasc Pharmacol       Date:  2022-09-01       Impact factor: 3.271

2.  Metoprolol Mitigates Ischemic Heart Remodeling and Fibrosis by Increasing the Expression of AKAP5 in Ischemic Heart.

Authors:  Feng Zhu; Qiushu Wang; Zhi Wang; Xu Zhang; Benkai Zhang; Hegui Wang
Journal:  Oxid Med Cell Longev       Date:  2022-10-04       Impact factor: 7.310

3.  β-blockers Reverse Agonist-Induced β2-AR Downregulation Regardless of Their Signaling Profile.

Authors:  Sonia Maccari; Vanessa Vezzi; Federica Barbagallo; Tonino Stati; Barbara Ascione; Maria Cristina Grò; Liviana Catalano; Giuseppe Marano; Paola Matarrese; Caterina Ambrosio; Paola Molinari
Journal:  Int J Mol Sci       Date:  2020-01-14       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.